Vana Sypsa
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 68
- HIV, Drug Use, Sexual Risk 29
- Hepatitis B Virus Studies 22
- Liver Disease Diagnosis and Treatment 17
- Hepatology 35
- Hepatitis C virus research 34
- Co-authors
- Angelos Hatzakis (82 shared papers)Dimitrios Paraskevis (51 shared papers)Georgios K. Nikolopoulos (21 shared papers)Athanasios Skoutelis (6 shared papers)Mina Psichοgiou (25 shared papers)Meni Malliori (14 shared papers)Samuel R. Friedman (17 shared papers)George L. Daikos (3 shared papers)
- Journals
- Journal of Hepatology (11 papers)Journal of Viral Hepatitis (9 papers)PLoS ONE (8 papers)AIDS and Behavior (5 papers)Addiction (4 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Vana Sypsa
121 papers receiving 3.3k citations
Vana Sypsa's Hit Papers
Peers
Comparison fields: 5 of 124
- Hepatology 746
- Molecular Medicine 437
- Virology 297
- Applied Microbiology and Biotechnology 106
- Epidemiology 1.6k
Countries citing papers authored by Vana Sypsa
This map shows the geographic impact of Vana Sypsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vana Sypsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vana Sypsa more than expected).
Fields of papers citing papers by Vana Sypsa
This network shows the impact of papers produced by Vana Sypsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vana Sypsa. The network helps show where Vana Sypsa may publish in the future.
Co-authors
The 25 scholars most cited alongside Vana Sypsa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems Hit paper breakdown → | 2014 | 467 |
| 2 | 2007 | 167 | |
| 3 | 2009 | 160 | |
| 4 | 2014 | 119 | |
| 5 | 2009 | 95 | |
| 6 | 1998 | 91 | |
| 7 | 2013 | 86 | |
| 8 | 2005 | 72 | |
| 9 | 2006 | 70 | |
| 10 | 2002 | 68 | |
| 11 | 2011 | 67 | |
| 12 | 2016 | 60 | |
| 13 | 2020 | 59 | |
| 14 | 2007 | 53 | |
| 15 | 2003 | 53 | |
| 16 | 2021 | 53 | |
| 17 | 2015 | 53 | |
| 18 | 2005 | 52 | |
| 19 | 2013 | 49 | |
| 20 | 2014 | 46 |
About Vana Sypsa
Vana Sypsa is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Virology and General Health Professions, having authored 127 papers that have together received 3.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (34 papers), HIV, Drug Use, Sexual Risk (29 papers), Hepatitis B Virus Studies (22 papers), Liver Disease Diagnosis and Treatment (17 papers), HIV/AIDS Research and Interventions (17 papers), HIV Research and Treatment (13 papers), COVID-19 epidemiological studies (8 papers) and HIV/AIDS drug development and treatment (7 papers). The work is most often cited by research in Hepatology (746 citations), Molecular Medicine (437 citations), Virology (297 citations), Applied Microbiology and Biotechnology (106 citations) and Epidemiology (1.6k citations). Vana Sypsa has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Angelos Hatzakis, Dimitrios Paraskevis, Georgios K. Nikolopoulos, Athanasios Skoutelis, Mina Psichοgiou, Meni Malliori, Samuel R. Friedman, George L. Daikos, Vivì Miriagou and L. S. Tzouvelekis. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, PLoS ONE, AIDS and Behavior and Addiction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.